Motor Control Exercises and Neural Mobilization in Posture of Older Adults

April 11, 2022 updated by: Riphah International University

Effects of Motor Control Exercises With and Without Neural Mobilization on Postural Control of Older Adults

The aim of this research is to find and compare the effect of Motor control exercises with and without neural mobilization on postural control of older adults.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Randomized controlled trials done at Bilqees Eidhi and Afiyat old age home Lahore.The sample size was 40. The subjects were divided in two groups, 20 subjects in Motor control exercise group and 20 in Motor control exercise with neural gliding group. Study duration was of 6 months. Sampling technique applied was purposive non probability sampling technique. Only 65-80 years of older adults included in study. Tools used in the study are time up and go test(TUG), Gait speed, Static balance and Quality of life(OPQOL35). Data was analyzed through SPSS 21.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Pakistan
    • Punjab
      • Lahore, Punjab, Pakistan, 54000
        • Binash afzal

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria

  • Both male and female were included
  • Older adults having age range from 60-80 years or older
  • Adults whose score is more than 24 on mini mental state examination.
  • Ambulate independently with or without a walking aid
  • Adults who had permission from the institution's doctor to participate in exercise classes.

Exclusion Criteria:

  • Patients with altered conscious level
  • Adults who cannot ambulate (bed ridden patients)
  • Patient with any neurological condition like stroke, multiple sclerosis and TBI
  • Patients with severe orthopedic condition like fractures and rheumatoid arthritis
  • Patient having any cardiac condition
  • Adults walking with walking aids like sick and crutches
  • Adults having vertigo or vestibular problems.
  • Adults having history of recurrent falls.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Motor control exercise
Motor control exercise was given with total of 8 sessions for 30 min for 4 weeks twice a day. Each exercise was performed 10 repetitions for 10 sec.
Other: Motor control exercise
Motor control exercise was given with total of 8 sessions for 30 min for 4 weeks twice a day. Each exercise was performed 10 repetitions for 10 sec.
Active Comparator: Motor control exercise with neural mobilization
this was given motor control exercise for 30 min, 4 weeks twice a day plus neural gliding applied for 3 sets of 10 repetitions on each session. Neural gliding applied 5 min before motor control exercise. Total 8 sessions were given
Other: Motor control exercise with mobilization
this was given motor control exercise for 30 min, 4 weeks twice a day plus neural gliding applied for 3 sets of 10 repetitions on each session. Neural gliding applied 5 min before motor control exercise. Total 8 sessions were given

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Static balance test
Time Frame: first reading at 0 week
Balance will be assessed using the Tandem stance (TS) test for static balance. The intraobserver reliability of the test is good with an ICC of 0.80.
first reading at 0 week
Static balance test
Time Frame: final reading at end of 4 week
Balance will be assessed using the Tandem stance (TS) test for static balance. The intraobserver reliability of the test is good with an ICC of 0.80.
final reading at end of 4 week
Gait speed test
Time Frame: first reading at 0 week
The 4-m gait speed test will use, and the beginning and the end of the test will mark on the floor. The intra-observer reliability of the gait speed test is excellent with an ICC of 0.91, a standard error of measurement of 0.06 m/s, and a minimum detectable difference (MDD) of 0.17 m/s.
first reading at 0 week
Gait speed test
Time Frame: final reading at end of 4 week
The 4-m gait speed test will use, and the beginning and the end of the test will mark on the floor. The intra-observer reliability of the gait speed test is excellent with an ICC of 0.91, a standard error of measurement of 0.06 m/s, and a minimum detectable difference (MDD) of 0.17 m/s.
final reading at end of 4 week
Timed Up and Go test
Time Frame: first reading at 0 week
Timing began when participants initiate standing and end when they sat down. The mean of the measurements will be use for statistical purposes. The inter-observer reliability is good with an ICC of 0.89, a standard error of measurement of 3.99 seconds, and an MDD of 11.06 seconds.
first reading at 0 week
Timed Up and Go test
Time Frame: final reading at 4 week
Timing began when participants initiate standing and end when they sat down. The mean of the measurements will be use for statistical purposes. The inter-observer reliability is good with an ICC of 0.89, a standard error of measurement of 3.99 seconds, and an MDD of 11.06 seconds.
final reading at 4 week
Quality of life: (OPQOL 35)
Time Frame: first reading at 0 week
OPQOL questionnaire, has been validated in a multiethnic community-dwelling older population in England. Cronbach's alpha coefficient for the Italian outpatient population enrolled in this study was found to be 0.78, i.e. above the 0.70 threshold of acceptability for internal consistency.
first reading at 0 week
Quality of life: (OPQOL 35)
Time Frame: final reading at 4 week
OPQOL questionnaire, has been validated in a multiethnic community-dwelling older population in England. Cronbach's alpha coefficient for the Italian outpatient population enrolled in this study was found to be 0.78, i.e. above the 0.70 threshold of acceptability for internal consistency.
final reading at 4 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Riphah International University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 15, 2021

Primary Completion (Actual)

October 15, 2021

Study Completion (Actual)

December 15, 2021

Study Registration Dates

First Submitted

January 21, 2022

First Submitted That Met QC Criteria

April 11, 2022

First Posted (Actual)

April 19, 2022

Study Record Updates

Last Update Posted (Actual)

April 19, 2022

Last Update Submitted That Met QC Criteria

April 11, 2022

Last Verified

April 1, 2022

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • RiphahIU Raana Rubab

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postural Control

Clinical Trials on Motor control exercise

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Indonesia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe